uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The antihypertensive response to irbesartan treatment from a pharmacogenetic perspective.
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences. (Akut- och internmedicin)
2003 (English)In: Minerva Med, ISSN 0026-4806, Vol. 94, no 4, 251-8 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2003. Vol. 94, no 4, 251-8 p.
Keyword [en]
Antihypertensive Agents/*therapeutic use, Biphenyl Compounds/*therapeutic use, Cytochrome P-450 CYP2D6/genetics, Humans, Hypertension/*drug therapy/genetics, Pharmacogenetics, Pharmacokinetics, Polymorphism; Genetic, Renin-Angiotensin System/genetics, Tetrazoles/*therapeutic use
Identifiers
URN: urn:nbn:se:uu:diva-73405PubMedID: 14605589OAI: oai:DiVA.org:uu-73405DiVA: diva2:101315
Available from: 2005-06-03 Created: 2005-06-03 Last updated: 2011-01-13

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=14605589&dopt=Citation

Authority records BETA

Kurland, L

Search in DiVA

By author/editor
Kurland, L
By organisation
Department of Medical Sciences

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 473 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf